O
Olga Uspenskaya
Researcher at Ludwig Maximilian University of Munich
Publications - 10
Citations - 2728
Olga Uspenskaya is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Natriuretic peptide & Atrial natriuretic peptide. The author has an hindex of 7, co-authored 9 publications receiving 2283 citations.
Papers
More filters
Journal ArticleDOI
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Frank Jessen,Frank Jessen,Rebecca E. Amariglio,Martin P.J. van Boxtel,Monique M.B. Breteler,Mathieu Ceccaldi,Gaël Chételat,Bruno Dubois,Carole Dufouil,Kathryn A. Ellis,Wiesje M. van der Flier,Lidia Glodzik,Argonde C. van Harten,Mony J. de Leon,Pauline McHugh,Michelle M. Mielke,José Luis Molinuevo,Lisa Mosconi,Ricardo S. Osorio,Audrey Perrotin,Ronald C. Petersen,Laura A. Rabin,Lorena Rami,Barry Reisberg,Dorene M. Rentz,Perminder S. Sachdev,Vincent de La Sayette,Andrew J. Saykin,Philip Scheltens,Melanie B. Shulman,Melissa J. Slavin,Reisa A. Sperling,Robert Stewart,Olga Uspenskaya,Bruno Vellas,Pieter Jelle Visser,Pieter Jelle Visser,Michael Wagner,Michael Wagner +38 more
TL;DR: Research criteria for SCD in pre‐mild cognitive impairment (MCI) are presented and a list of core features proposed for reporting in SCD studies is provided, which will enable comparability of research across different settings.
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Frank Jessen,Frank Jessen,Rebecca E. Amariglio,Martin P.J. van Boxtel,Monique M.B. Breteler,Mathieu Ceccaldi,Gaël Chételat,Bruno Dubois,Carole Dufouil,Kathryn A. Ellis,Wiesje M. van der Flier,Lidia Glodzik,Argonde C. van Harten,Mony J. de Leon,Pauline McHugh,Michelle M. Mielke,José Luis Molinuevo,Lisa Mosconi,Ricardo S. Osorio,Audrey Perrotin,Ronald C. Petersen,Laura A. Rabin,Lorena Rami,Barry Reisberg,Dorene M. Rentz,Perminder S. Sachdev,Vincent de La Sayette,Andrew J. Saykin,Philip Scheltens,Melanie B. Shulman,Melissa J. Slavin,Reisa A. Sperling,Robert Stewart,Olga Uspenskaya,Bruno Vellas,Pieter Jelle Visser,Pieter Jelle Visser,Michael Wagner,Michael Wagner +38 more
TL;DR: In this paper, research criteria for subjective cognitive decline in individuals with unimpaired performance on cognitive tests may represent the first symptomatic manifestation of Alzheimer's disease (AD) are presented.
Journal ArticleDOI
Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).
Katharina Buerger,Giovanni B. Frisoni,Olga Uspenskaya,Michael Ewers,Michael Ewers,Henrik Zetterberg,Cristina Geroldi,Giuliano Binetti,Peter Johannsen,Paolo Maria Rossini,Lars-Olof Wahlund,Bruno Vellas,Kaj Blennow,Harald Hampel,Harald Hampel +14 more
TL;DR: The use of frozen rather than fresh samples renders higher diagnostic accuracy within a multicentre context, and confirmed the feasibility of aMulticentre AD biomarker programme for future clinical trials.
Journal ArticleDOI
Blood-Based Microcirculation Markers in Alzheimer's Disease–Diagnostic Value of Midregional Pro-atrial Natriuretic Peptide/C-terminal Endothelin-1 Precursor Fragment Ratio
Katharina Buerger,Andrea Ernst,Michael Ewers,Michael Ewers,Olga Uspenskaya,Muamer Omerovic,Nils G. Morgenthaler,Katharina Knauer,Andreas Bergmann,Harald Hampel,Harald Hampel +10 more
TL;DR: The hypothesis of a disturbed microvascular homeostasis in AD is supported by the hypothesis that the vasodilator/vasoconstrictor ratios hold promise as a diagnostic marker of AD.
Journal ArticleDOI
Prediction of Alzheimer's Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic Peptide: A Retrospective Analysis of 134 Patients With Mild Cognitive Impairment
Katharina Buerger,Olga Uspenskaya,Oliver Hartmann,Oskar Hansson,Lennart Minthon,Kaj Blennow,Hans-Juergen Moeller,Stefan J. Teipel,Andrea Ernst,Andreas Bergmann,Harald Hampel +10 more
TL;DR: This study shows that plasma concentrations of MR-proANP and MR- proADM have predictive value in the progression from predementia MCI to clinical AD, which may recommend this test for first-stage screening in patients at risk for AD.